{
  "id": 19347488,
  "title": "STAT+: Pharmalittle: We’re reading about an approval for novel drug for strokes, a warning for GLP-1 drugs, and more",
  "url": "https://urgent.news/2026/11/10/stat-pharmalittle-were-reading-about-an-approval-for-novel-drug-for",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-10T14:25:24.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/pharmalot/2026/11/10/stroke-drug-sunharbo-eye-warning-glp-drugs-pharmalittle/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The FDA approved a novel drug to reduce recurrence of stroke, the agency is warning that GLP-1s carry a potential risk for an eye condition, and more pharma news of…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}